The gastrointestinal effects, including nausea, vomiting, diarrhea, and constipation , affect roughly 40-50% of users at therapeutic doses
Silymarin works through multiple mechanisms: it acts as an antioxidant protecting liver cells from oxidative damage, it inhibits the binding of toxins to liver cell membrane receptors, and it stimulates protein synthesis, which promotes the regeneration of damaged liver cells
Do not expose to excessive heat, moisture or sunlight
GLP-1 receptor agonists also reduce the three components of MACE, including CV mortality (reduced by 13%), nonfatal stroke (reduced by 16%) and nonfatal myocardial infarction (reduced by 9%, although the level of significance was not reached)